Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Efficacy of intralesional corticosteroids in the treatment of cylindromas.

Mulder KM, Crijns MB, van Doorn R.

Clin Exp Dermatol. 2016 Jul;41(5):578-80. doi: 10.1111/ced.12873. No abstract available.

PMID:
27324556
2.

[A toddler with an itchy, brown rash].

Mulder KM, Vermeer MH.

Ned Tijdschr Geneeskd. 2016;160:A9630. Dutch.

PMID:
26786799
3.

A dynein motor attachment complex regulates TGFß/Smad3 signaling.

Jin Q, Gao G, Mulder KM.

Int J Biol Sci. 2013 Jun 9;9(6):531-40. doi: 10.7150/ijbs.5718. Print 2013.

4.

Decreased tumor progression and invasion by a novel anti-cell motility target for human colorectal carcinoma cells.

Jin Q, Liu G, Domeier PP, Ding W, Mulder KM.

PLoS One. 2013 Jun 3;8(6):e66439. doi: 10.1371/journal.pone.0066439. Print 2013.

5.

Requirement for protein kinase A in the phosphorylation of the TGFβ receptor-interacting protein km23-1 as a component of TGFβ downstream effects.

Jin Q, Zhong Y, Mulder KM.

Exp Cell Res. 2013 Apr 1;319(6):897-907. doi: 10.1016/j.yexcr.2012.12.029. Epub 2013 Jan 16. Erratum in: Exp Cell Res. 2013 Aug 15;319(14):2307-8.

6.

Role of km23-1 in RhoA/actin-based cell migration.

Jin Q, Pulipati NR, Zhou W, Staub CM, Liotta LA, Mulder KM.

Biochem Biophys Res Commun. 2012 Nov 23;428(3):333-8. doi: 10.1016/j.bbrc.2012.10.047. Epub 2012 Oct 15.

7.

The TGFβ receptor-interacting protein km23-1/DYNLRB1 plays an adaptor role in TGFβ1 autoinduction via its association with Ras.

Jin Q, Ding W, Mulder KM.

J Biol Chem. 2012 Jul 27;287(31):26453-63. doi: 10.1074/jbc.M112.344887. Epub 2012 May 27.

8.

Requirement of a dynein light chain in transforming growth factor β signaling in zebrafish ovarian follicle cells.

Jin Q, Gao G, Mulder KM.

Mol Cell Endocrinol. 2012 Jan 2;348(1):233-40. doi: 10.1016/j.mce.2011.08.029. Epub 2011 Sep 5.

9.

Lipofilling with minimal access cranial suspension lifting for enhanced rejuvenation.

Willemsen JC, Mulder KM, Stevens HP.

Aesthet Surg J. 2011 Sep;31(7):759-69. doi: 10.1177/1090820X11418332.

PMID:
21908808
10.

Overexpression of the dynein light chain km23-1 in human ovarian carcinoma cells inhibits tumor formation in vivo and causes mitotic delay at prometaphase/metaphase.

Pulipati NR, Jin Q, Liu X, Sun B, Pandey MK, Huber JP, Ding W, Mulder KM.

Int J Cancer. 2011 Aug 1;129(3):553-64. doi: 10.1002/ijc.25954. Epub 2011 Apr 25.

11.

Knockdown of c-Fos suppresses the growth of human colon carcinoma cells in athymic mice.

Pandey MK, Liu G, Cooper TK, Mulder KM.

Int J Cancer. 2012 Jan 1;130(1):213-22. doi: 10.1002/ijc.25997. Epub 2011 Apr 8.

12.

Atherosclerosis in patients with cyanotic congenital heart disease.

Duffels MG, Mulder KM, Trip MD, de Groot E, Gort J, van Dijk AP, Hoendermis ES, Daliento L, Zwinderman AH, Berger RM, Mulder BJ.

Circ J. 2010 Jul;74(7):1436-41. Epub 2010 Jun 4.

13.

Requirement of a dynein light chain in TGFbeta/Smad3 signaling.

Jin Q, Gao G, Mulder KM.

J Cell Physiol. 2009 Dec;221(3):707-15. doi: 10.1002/jcp.21910.

14.

Requirement for the dynein light chain km23-1 in a Smad2-dependent transforming growth factor-beta signaling pathway.

Jin Q, Ding W, Mulder KM.

J Biol Chem. 2007 Jun 29;282(26):19122-32. Epub 2007 Apr 9.

15.

Requirement of Smad3 and CREB-1 in mediating transforming growth factor-beta (TGF beta) induction of TGF beta 3 secretion.

Liu G, Ding W, Neiman J, Mulder KM.

J Biol Chem. 2006 Oct 6;281(40):29479-90. Epub 2006 Aug 4.

16.
17.

Structure and dynamics of the homodimeric dynein light chain km23.

Ilangovan U, Ding W, Zhong Y, Wilson CL, Groppe JC, Trbovich JT, Zúñiga J, Demeler B, Tang Q, Gao G, Mulder KM, Hinck AP.

J Mol Biol. 2005 Sep 16;352(2):338-54.

PMID:
16083906
18.

A transforming growth factor-beta receptor-interacting protein frequently mutated in human ovarian cancer.

Ding W, Tang Q, Espina V, Liotta LA, Mauger DT, Mulder KM.

Cancer Res. 2005 Aug 1;65(15):6526-33.

19.

Requirement of km23 for TGFbeta-mediated growth inhibition and induction of fibronectin expression.

Jin Q, Ding W, Staub CM, Gao G, Tang Q, Mulder KM.

Cell Signal. 2005 Nov;17(11):1363-72. Epub 2005 Mar 31.

PMID:
15925487
20.

km23: a novel TGFbeta signaling target altered in ovarian cancer.

Ding W, Mulder KM.

Cancer Treat Res. 2004;119:315-27. Review. No abstract available.

PMID:
15164884
22.

A novel transforming growth factor-beta receptor-interacting protein that is also a light chain of the motor protein dynein.

Tang Q, Staub CM, Gao G, Jin Q, Wang Z, Ding W, Aurigemma RE, Mulder KM.

Mol Biol Cell. 2002 Dec;13(12):4484-96.

23.

Transforming growth factor-beta signal transduction in epithelial cells.

Yue J, Mulder KM.

Pharmacol Ther. 2001 Jul;91(1):1-34. Review.

PMID:
11707292
26.

Activation of the mitogen-activated protein kinase pathway by transforming growth factor-beta.

Yue J, Mulder KM.

Methods Mol Biol. 2000;142:125-31. Review. No abstract available.

PMID:
10806618
27.

Role of Ras and Mapks in TGFbeta signaling.

Mulder KM.

Cytokine Growth Factor Rev. 2000 Mar-Jun;11(1-2):23-35. Review.

PMID:
10708950
28.

Cross-talk between the Smad1 and Ras/MEK signaling pathways for TGFbeta.

Yue J, Frey RS, Mulder KM.

Oncogene. 1999 Mar 18;18(11):2033-7.

29.

Cloning and expression of a rat Smad1: regulation by TGFbeta and modulation by the Ras/MEK pathway.

Yue J, Hartsough MT, Frey RS, Frielle T, Mulder KM.

J Cell Physiol. 1999 Mar;178(3):387-96.

PMID:
9989785
30.

Transforming growth factor beta signaling through Smad1 in human breast cancer cells.

Liu X, Yue J, Frey RS, Zhu Q, Mulder KM.

Cancer Res. 1998 Oct 15;58(20):4752-7.

31.
32.

TGFbeta regulation of mitogen-activated protein kinases in human breast cancer cells.

Frey RS, Mulder KM.

Cancer Lett. 1997 Jul 15;117(1):41-50.

PMID:
9233830
34.

Transforming growth factor-beta signaling in epithelial cells.

Hartsough MT, Mulder KM.

Pharmacol Ther. 1997;75(1):21-41. Review.

PMID:
9364579
35.

Altered transforming growth factor signaling in epithelial cells when ras activation is blocked.

Hartsough MT, Frey RS, Zipfel PA, Buard A, Cook SJ, McCormick F, Mulder KM.

J Biol Chem. 1996 Sep 13;271(37):22368-75.

36.

Maintenance of growth factor signaling through Ras in human colon carcinoma cells containing K-ras mutations.

Buard A, Zipfel PA, Frey RS, Mulder KM.

Int J Cancer. 1996 Aug 7;67(4):539-46.

37.

Clonal heterogeneity of the sensitivity of human colon carcinoma cell lines to TGE beta isoforms.

Zhou GH, Sechrist GL, Brattain MG, Mulder KM.

J Cell Physiol. 1995 Dec;165(3):512-20.

PMID:
7593230
38.

Transforming growth factor beta isoform-specific differences in interactions with type I and II transforming growth factor beta receptors.

Zhou GH, Sechrist GL, Periyasamy S, Brattain MG, Mulder KM.

Cancer Res. 1995 May 15;55(10):2056-62.

39.
41.

Role of receptor complexes in resistance or sensitivity to growth inhibition by TGF beta in intestinal epithelial cell clones.

Mulder KM, Segarini PR, Morris SL, Ziman JM, Choi HG.

J Cell Physiol. 1993 Jan;154(1):162-74.

PMID:
8380421
42.

Activation of p21ras by transforming growth factor beta in epithelial cells.

Mulder KM, Morris SL.

J Biol Chem. 1992 Mar 15;267(8):5029-31.

43.

TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector.

Wu SP, Theodorescu D, Kerbel RS, Willson JK, Mulder KM, Humphrey LE, Brattain MG.

J Cell Biol. 1992 Jan;116(1):187-96.

45.

Evidence for c-myc in the signaling pathway for TGF-beta in well-differentiated human colon carcinoma cells.

Mulder KM, Humphrey LE, Choi HG, Childress-Fields KE, Brattain MG.

J Cell Physiol. 1990 Dec;145(3):501-7.

PMID:
2273056
47.
49.

Up-regulation of c-myc in a transformed cell line approaching stationary phase growth in culture.

Mulder KM, Levine AE, Hinshaw XH.

Cancer Res. 1989 May 1;49(9):2320-6.

50.

Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-beta 1.

Hoosein NM, McKnight MK, Levine AE, Mulder KM, Childress KE, Brattain DE, Brattain MG.

Exp Cell Res. 1989 Apr;181(2):442-53.

PMID:
2538337

Supplemental Content

Loading ...
Support Center